1-4 of 4
Balu Wu
Close
Sort by
Journal Articles

Circ_0100160 Derived from FLT3 Is a Novel Diagnostic Biomarker in Acute Myeloid Leukemia

Yuxing Liang, Balu Wu, Nan Zhang, Fuling Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 11783.
https://doi.org/10.1182/blood-2022-165410
Published: 2022
Journal Articles

Therapeutic Effect of a Traditional Chinese Medicine Compound Mixture Compound Kushen Injection in Treating Multiple Myeloma

Hongqiang Jiang, PhD, Honglei Tu, Yanxia Jin, PhD, Xianjin Wu, Ziyi Luo, Yanling Chen, Dongdong Zhang, PhD, Balu Wu, Yongchang Wei, Yi Yang, Fuling Zhou, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-141929
Published: 2020
Journal Articles

Recombinant Human Thrombopoietin in the Treatment of Chemotherapy-Induced Thrombocytopenia in Acute Myeloid Leukemia

Can Can, Lu Ding, Yuxin Tan, Balu Wu, Dongdong Zhang, PhD, Yanling Chen, Ziyi Luo, Xiaoyan Liu, Li Liu, Hui Shen, Fuling Zhou, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-141328
Published: 2020
Journal Articles

Analysis of Differential Circrnas Expression Profile Identifies Novel Biomarkers for Acute Monocytic Leukemia

Balu Wu, Sr., MD, Yunbao Pan, Sr., Yanxia Jin, PhD, Mingfeng Zhao, MD PhD, Fuling Zhou, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4948.
https://doi.org/10.1182/blood-2018-99-116399
Published: 2018